Aemetis (AMTX)
(Delayed Data from NSDQ)
$2.67 USD
-0.04 (-1.48%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $2.67 0.00 (0.00%) 6:06 PM ET
4-Sell of 5 4
C Value A Growth F Momentum A VGM
Aemetis (AMTX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.25 | $28.00 | $3.00 | 388.93% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Aemetis comes to $13.25. The forecasts range from a low of $3.00 to a high of $28.00. The average price target represents an increase of 388.93% from the last closing price of $2.71.
Analyst Price Targets (3 )
Broker Rating
Aemetis currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/AMTX.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.50 | 2.50 | 2.50 | 2.50 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/2/2024 | H.C. Wainwright & Co. | Amit Dayal | Strong Buy | Strong Buy |
6/14/2024 | UBS | Manav Gupta | Strong Buy | Strong Buy |
5/13/2024 | Truist Securities | Jordan Levy | Hold | Hold |
4/18/2024 | Piper Sandler | Ryan M Todd | Strong Sell | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 4 |
Average Target Price | $13.25 |
LT Growth Rate | NA |
Industry | Biofuels |
Industry Rank by ABR | 194 of 253 |
Current Quarter EPS Est: | -0.50 |